Fentanyl execution gets go-ahead in federal court
August 14, 2018Manufacturing and Production Nebraska, execution, fatalities, fentanyl, valium
The first execution in the United States using the powerful opioid fentanyl, is set to take place in Nebraska on …
NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay
August 14, 2018Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy
UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …
Researchers design new class of drugs to counter cardiovascular disease
August 14, 2018Manufacturing and Production TMAO, cardiovascular, gut microbe, heart attack, research
Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …
“Radical radiotherapy” cuts required treatments from 37 to 5
August 14, 2018Manufacturing and Production Cancer, oncology, pharma, radiotherapy
Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …
Rare lung cancer drug approved in Scotland
August 14, 2018Manufacturing and Production Cancer, SMC, Scotland, Scottish Medicines Consortium, approval, lung cancer
The Scottish Medicines Consortium has approved Roche’s cancer drug alectinib for the treatment of patients with untreated advanced non-small-cell lung …
Working Life: Nawal Ouzren, CEO of Sensorion
August 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma
Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …
Indicted GOP congressman Chris Collins’ terminates re-election campaign
August 13, 2018Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma
Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …
Astellas acquires gene therapy group Quethera in £85 million deal
August 13, 2018Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision
The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
FDA approves RNA therapy for rare genetic disease
August 13, 2018Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases
The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …
Chicago Judge overturns $140 million AbbVie AndroGel verdict
August 13, 2018Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone
A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
FDA approves first oral therapy for rare Fabry disease
August 13, 2018Sales and Marketing FDA, Fabry disease, US, pharma
Amicus has revealed that its therapy Galafold (migalastat) has been awarded approval by the FDA in the treatment of adult …
NHS scraps restriction on availability of J&J’s Imbruvica in leukaemia patients
August 10, 2018Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, NHS, NICE, UK, imbruvica, leukaemia, pharma
The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), …
Top Ten most popular articles on Pharmafile.com this week
August 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10
There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
Letters to doctors reduce opioid prescriptions, study shows
August 10, 2018Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study
A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …
FDA approved more generics in July than any previous month
August 10, 2018Medical Communications FDA, generics, pharma
FDA Commissioner Scott Gottlieb took to Twitter to announce the news that the FDA smashed its previous record for number …
ABPI Chief warns of Brexit impact on EU
August 10, 2018Medical Communications ABPI, EU, UK, brexit, trade lobby
The head of the Association of the British Pharmaceutical Industry (ABPI) has warned that European governments have failed to recognise …
US Congressman arrested over insider trading in biopharma firm
August 9, 2018Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma
A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …
FDA expands list of valsartan recalls
August 9, 2018Medical Communications China, FDA, US, heart medication, recall, valsartan
The US Food and Drug Administration (FDA) has expanded a list of products containing valsartan that are to be recalled. …
NICE recommends Eli Lilly’s psoriatic arthritis drug
August 9, 2018Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis
Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
NICE recommends Pfizer’s Besponsa in rare leukaemia following review
August 9, 2018Sales and Marketing NICE, Pfizer, leukaemia, pharma
Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
